Related Experiment Videos
Does ACE inhibitor modify the morphofunctional state of the nephron?
Ewa Kifer-Wysocka1, Jadwiga Romanowska-Sarlej, Włodzimierz Matysiak
1Department of Histology and Embryology, Medical University of Lublin.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina
|August 6, 2003
Summary
Captopril, an angiotensin-converting enzyme (ACE) inhibitor, caused temporary kidney cell changes in rats. Higher doses led to more pronounced morphofunctional alterations in nephron structures.
Area of Science:
- Nephrology
- Pharmacology
- Cell Biology
Background:
- Angiotensin-converting enzyme (ACE) inhibitors are widely used in treating hypertension and heart failure.
- Understanding the cellular effects of ACE inhibitors on kidney function is crucial for patient safety.
Purpose of the Study:
- To investigate the morphofunctional changes in rat kidneys following administration of Captopril.
- To assess the dose-dependent effects of Captopril on nephron structures.
Main Methods:
- Administration of Captopril to white rats at two different doses (0.23 mg/day/rat and 0.71 mg/day/rat) for 3 weeks.
- Examination of kidney tissues using a transmission electron microscope.
Main Results:
- Observed cytoplasmic dilution, apical and basal vacuoles, intercellular space dilation, and increased lysosomes in proximal tubule cells.
- These changes were more distinct in rats receiving the higher Captopril dose.
- Electron microscopy revealed dose-dependent morphofunctional alterations in the nephron.
Conclusions:
- Captopril administration induces temporary, dose-dependent morphofunctional changes in rat kidney nephrons.
- These findings highlight the potential for ACE inhibitors to modulate kidney structure at the cellular level.